公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2017 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small-cell Lung Cancer | YEN-TING LIN ; Liu Y.-N.; SHANG-GIN WU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Clinical Lung Cancer | 32 | 26 | |
2015 | Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis | BIN-CHI LIAO ; JIH-HSIANG LEE ; CHIA-CHI LIN ; YA-FANG CHEN ; Chang C.-H.; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 137 | 113 | |
2019 | Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI | Weng, C.-H.; Chen, L.-Y.; Lin, Y.-C.; JIN-YUAN SHIH ; Lin, Y.-C.; Tseng, R.-Y.; Chiu, A.-C.; Yeh, Y.-H.; Liu, C.; Lin, Y.-T.; Fang, J.-M. ; CHING-CHOW CHEN | Oncogene | 158 | 137 | |
2021 | Establishing Aspergillus-Specific IgG Cut-Off Level for Chronic Pulmonary Aspergillosis Diagnosis: Multicenter Prospective Cohort Study | MENG-RUI LEE ; Huang, Hung-Ling; LI-TA KENG ; Chang, Hsu-Liang; Sheu, Chau-Chyun; Fu, Pin-Kuei; JANN-YUAN WANG ; Chong, Inn-Wen; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of fungi (Basel, Switzerland) | 6 | 5 | |
2015 | Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer | CHUNG-YU CHEN ; JOU-WEI LIN ; JENQ-WEN HUANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Clinical Lung Cancer | 10 | 10 | |
2006 | Estrogen receptor β - Which one and where should we draw the line - Reply [2] | CHEN-TU WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Lee Y.-C. | Human Pathology | 0 | 0 | |
2021 | Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations | Chang G.-C.; Lam D.C.-L.; Tsai C.-M.; Chen Y.-M.; JIN-YUAN SHIH ; Aggarwal S.; Wang S.; Kim S.-W.; Kim Y.-C.; Wahid I.; Li R.; Lim D.W.-T.; Sriuranpong V.; Chan R.T.-T.; Lorence R.M.; Carriere P.; Raabe C.; Cseh A.; Park K. | International Journal of Clinical Oncology | 2 | 2 | |
2017 | Expression of notch gene and its impact on survival of patients with resectable non-small cell lung cancer | CHUNG-YU CHEN ; Chen Y.-Y.; MIN-SHU HSIEH ; CHAO-CHI HO ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Cancer | 25 | 23 | |
2008 | Extensive GI tract involvement of Ewing's sarcoma/peripheral primitive neuroectodermal tumor in an octogenarian | Lin P.-Y.; JIN-YUAN SHIH ; MU-ZON WU ; YU-TING CHANG ; PAN-CHYR YANG | Gastrointestinal Endoscopy | 1 | 1 | |
2010 | Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations | KUEI-PIN CHUNG ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Clinical Oncology | 9 | 8 | |
2008 | First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer | Wu J.-Y.; CHONG-JEN YU ; CHIH-HSIN YANG ; SHANG-GIN WU ; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG ; Hsu Y.-C.; Wei P.-F.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 69 | 62 | |
2004 | Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers | Lee Y.-C.; CHEN-TU WU ; JIN-YUAN SHIH ; Jou Y.-S.; YIH-LEONG CHANG | British Journal of Cancer | 14 | 14 | |
2013 | Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | SHANG-GIN WU ; Hu F.-C.; YIH-LEONG CHANG ; Lee Y.-C.; CHONG-JEN YU ; YEUN-CHUNG CHANG ; Wu J.-Y.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 35 | 36 | |
2008 | Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma | SHANG-GIN WU ; Gow C.-H.; CHONG-JEN YU ; YIH-LEONG CHANG ; CHIH-HSIN YANG ; Hsu Y.-C.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | European Respiratory Journal | 109 | 95 | |
2009 | From midbody protein - Protein interaction network construction to novel regulators in cytokinesis | Chen T.-C.; Lee S.-A.; Hong T.-M.; JIN-YUAN SHIH ; Lai J.-M.; Chiou H.-Y.; Yang S.-C.; Chan C.-H.; Kao C.-Y.; PAN-CHYR YANG ; Huang C.-Y.F. | Journal of Proteome Research | 23 | 22 | |
2020 | Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma | Lu, Hsuan-Hsuan; SHU-YUNG LIN ; Weng, Rueyhung Roc; Juan, Yi-Hsiu; Chen, Yen-Wei; HSIN-HAN HOU ; Hung, Zheng-Ci; Oswita, Giovanni Audrey; Huang, Yi-Jhen; Guu, Shih-Yun; Khoo, Kay-Hooi; JIN-YUAN SHIH ; CHONG-JEN YU ; HSING-CHEN TSAI | EBioMedicine | 20 | 15 | |
2011 | Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations | Wu J.-Y.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Medicine | 32 | 27 | |
2005 | Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status | Su W.-P.; CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; CHIUN HSU ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 10 | |
2008 | Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial | CHIUN HSU ; SUNG-HSIN KUO ; Hu F.-C.; ANN-LII CHENG ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIA-CHI LIN ; Huang T.-C.; PAN-CHYR YANG ; CHIH-HSIN YANG | Lung Cancer | 14 | 11 | |
2012 | Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum | WEI-YU LIAO ; JIN-YUAN SHIH ; Chang G.-C.; Cheng Y.-K.; CHIH-HSIN YANG ; Chen Y.-M.; CHONG-JEN YU | Journal of Thoracic Oncology | 50 | 50 | |